FSD Pharma board of directors has approved the settlement of an aggregate of $637,650 of amounts owing to arm’s length creditors through the issuance of 545,000 Class B Subordinate Voting shares in the capital of the Corporation at the deemed price of $1.17 per Class B Share. The Company also announced that its board of directors has approved a grant of 55,000 restricted share units (“RSUs”) to various consultants of the Company pursuant to the Company’s equity incentive plan. Each RSU entitles the holder to acquire one Class B Share of the Company upon vesting
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HUGE: